Physician profile
Cara Hawthorne Smith
NPI 1497285381
$4,789.18
in general payments reported to CMS, 2019-2025
16 companies · $552 in 2025
The $552 reported for 2025 was more than what 80% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $722 · 2020: $110 · 2021: $870 · 2022: $899 · 2023: $733 · 2024: $902 · 2025: $552.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,188.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,188.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $1,160.53 | 2019-2025 | Rocklatan, Clareon, Precision7 |
| Johnson & Johnson Vision Care, INC. | $602.09 | 2019-2021 | |
| Biotissue Holdings INC. | $579.83 | 2024-2025 | |
| Bausch & Lomb Americas INC. | $372.35 | 2022-2025 | Miebo, Xiidra, Lotemax Sm |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $318.48 | 2019-2020 | |
| Oyster Point Pharma, INC. | $312.12 | 2022-2024 | Tyrvaya, Ryzumvi |
| Abbvie INC. | $261.60 | 2022-2024 | Xen Glaucoma Treatment System, Alphagan P, Lumigan |
| Coopervision INC. | $252.38 | 2021-2022 | |
| Glaukos Corporation | $242.58 | 2019-2023 | |
| Sun Pharmaceutical Industries INC. | $195.45 | 2023-2025 | Cequa |
| Shire North American Group INC | $123.90 | 2019 | |
| Harrow Eye, LLC | $108.09 | 2023-2024 | Iheezo, Vevye |
| Mallinckrodt Hospital Products INC. | $85.67 | 2022 | |
| New World Medical,INC. | $77.87 | 2025 | Kahook Dual Blade, Ahmed Glaucoma Valve, Streamline |
| Horizon Therapeutics Plc | $76.34 | 2022-2023 | Tepezza |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Rayner Intraocular Lenses Limited | $19.90 | 2023 | Rayone Spheric, Omidria, Rayone Aspheric |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Cara Smith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.